BMY: Income Statement for BRISTOL-MYERS SQUIBB - Yahoo!7 Finance

PERIOD ENDING		30-Sep-09	30-Jun-09	31-Mar-09	31-Dec-08
Total Revenue		5,487,000	5,384,000	5,015,000	5,249,000
Cost of Revenue		1,562,000	1,461,000	1,413,000	1,522,000

Gross Profit		3,925,000	3,923,000	3,602,000	3,727,000

	Operating Expenses
	Research Development	838,000	829,000	923,000	1,143,000
	Selling General and Administrative	1,478,000	1,477,000	1,388,000	1,734,000
	Non Recurring	54,000	48,000	131,000	(902,000)
	Others	-	-	-	-

	Total Operating Expenses	-	-	-	-


Operating Income or Loss		1,555,000	1,569,000	1,160,000	1,752,000

	Income from Continuing Operations
	Total Other Income/Expenses Net	30,000	22,000	78,000	70,000
	Earnings Before Interest And Taxes	1,724,000	1,741,000	1,384,000	1,961,000
	Interest Expense	-	-	-	73,000
	Income Before Tax	1,724,000	1,741,000	1,384,000	1,888,000
	Income Tax Expense	434,000	443,000	463,000	424,000
	Minority Interest	598,000	(598,000)	-	(266,000)

	Net Income From Continuing Ops	1,888,000	700,000	921,000	1,198,000

	Non-recurring Events
	Discontinued Operations	-	-	-	46,000
	Extraordinary Items	-	-	-	-
	Effect Of Accounting Changes	-	-	-	-
	Other Items	-	-	-	-


Net Income		1,888,000	700,000	921,000	1,244,000
Preferred Stock And Other Adjustments		(922,000)	283,000	(283,000)	-

Net Income Applicable To Common Shares		$966,000	$983,000	$638,000	$1,244,000

•

	Sign In [New User? Sign Up]	Finance Home \|Help

Bristol-Myers Squibb Co. (BMY)